Biotech deep tech funds invest at the intersection of biology and technology, backing companies that leverage AI-driven drug discovery, novel therapeutic modalities, and advanced diagnostics to fundamentally improve human health outcomes.
Showing 60 of 327 funds
Geneva, Switzerland
Boston, United States
Austin, United States
Menlo Park, United States
London, United Kingdom
Seattle, United States
Chicago, United States
San Francisco, United States
Waltham, United States
San Francisco, United States
Isle of Man, United Kingdom
London, United Kingdom
London, United Kingdom
Pasadena, United States
New York, United States
New York, United States
Stockholm, Sweden
Brooklyn, United States
Cambridge, United Kingdom
Berlin, Germany
Menlo Park, United States
Munich, Germany
Boston, United States
New York, United States
Chicago, United States
New York, United States
Boston, United States
San Francisco, United States
Berkeley, United States
Cambridge, United Kingdom
Cambridge, United States
San Francisco, United States
Austin, United States
La Jolla, United States
London, United Kingdom
Beijing, China
Boston, United States
Brussels, Belgium
San Francisco, United States
Berkeley, United States
Menlo Park, United States
Tokyo, Japan
Seattle, United States
London, United Kingdom
New York, United States
St. Louis, United States
Copenhagen, Denmark
San Diego, United States
Sydney, Australia
Ingelheim am Rhein, Germany
Santa Monica, United States
San Mateo, United States
Paris, France
Melbourne, Australia
San Francisco, United States
New York, United States
London, United Kingdom
Boston, United States
Seoul, South Korea